retatrutide type 2 diabetes trial Medscape | The investigational triple GLP-1/GIP/glucagon receptor agonist produced significant weight loss and A1c reduction in people Retatrutide Meets Phase 3 Weight-Loss

A combination of diet, exercise, supplementation, and lifestyle changes can aid GLP-1 secretion

Playing a Role in Maternal Health While most research has focused on the role glutathione plays in fetal health, studies suggest that this molecule also influences maternal health

Whilst some supplements (such as certain probiotics or omega-3 fatty acids) show promise in research settings, evidence remains preliminary

Balance Sheet as of March 31, 2026 At March 31, 2026, Viking held cash, cash equivalents and short-term investments of $603 million, compared to $706 million as of December 31, 2025

According to MEDVi's own published disclosures, compounded GLP-1 medications available through the platform are produced in facilities operating under applicable federal and state compounding regulations, but the company clearly states that the medications are not FDA-approved or evaluated for safety, efficacy, or quality as finished products